A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
We were formed as BioSig Technologies, Inc., a Nevada corporation, in February 2009 and in April 2011 we merged with our wholly owned subsidiary, BioSig Technologies, Inc., a Delaware corporation, with the Delaware corporation continuing as the surviving entity. BioSig is principally devoted to improving the standard of care in electrophysiology, or EP, with our PURE EP™ System’s enhanced signal acquisition, digital signal processing, and analysis during catheter ablation of cardiac arrhythmias. The Company has generated minimal revenue to date and consequently its operations are subject to all risks inherent in business enterprise in early commercialization stage. On November 7, 2018, we formed a subsidiary under the laws of the State of Delaware, originally under the name of NeuroClear Technologies, Inc., for the purpose of pursuing additional applications of the PURE EP™ signal processing technology outside of the field of cardiac electrophysiology.
| Metric | TTM | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | - | 0 | - | - |
| Net Income | -32M | -27M | -32M | -52M | -34M | -18M |
| EPS | $-5.60 | $-6.40 | $-9.50 | $-18.70 | $-16.50 | $-12.50 |
| Free Cash Flow | -20M | -22M | -27M | -27M | -16M | -10M |
| ROIC | -10373.8% | -6881.6% | -215.6% | -191.9% | -245.3% | -410.2% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 11.86 | 0.24 | 0.21 | 0.28 | 0.50 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -32M | -27M | -33M | -59M | -35M | -17M |
| Operating Margin | 0.0% | - | - | - | - | - |
| ROE | -13121.9% | -434.5% | -260.8% | -214.3% | -305.8% | -545.6% |
| Shares Outstanding | 75M | 4M | 3M | 3M | 2M | 1M |
Streamex Corp. passes 0 of 9 quality checks, indicating weak fundamentals.
Streamex Corp. (STEX) has a 5-year average return on invested capital (ROIC) of -191.9%. This is below average and may indicate limited pricing power.
Streamex Corp. (STEX) has a market capitalization of $77M. It is classified as a small-cap stock.
Streamex Corp. (STEX) does not currently pay a regular dividend.
Streamex Corp. (STEX) operates in the Electromedical & Electrotherapeutic Apparatus industry, within the Healthcare sector.
Streamex Corp. (STEX) generated $-22 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Streamex Corp. (STEX) has a debt-to-equity ratio of 11.86. This indicates higher leverage, which may increase financial risk.
Streamex Corp. (STEX) reported earnings per share (EPS) of $-6.40 in its most recent fiscal year.
Streamex Corp. (STEX) has a return on equity (ROE) of -434.5%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 10 years of financial data for Streamex Corp. (STEX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Streamex Corp. (STEX) has a book value per share of $0.07, based on its most recent annual SEC filing.